Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to -$135.0 million.

  • Select Medical Holdings' Cash from Financing Activities fell 14293.12% to -$135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$315.2 million, marking a year-over-year decrease of 3618.89%. This contributed to the annual value of -$311.2 million for FY2024, which is 498.23% up from last year.
  • According to the latest figures from Q3 2025, Select Medical Holdings' Cash from Financing Activities is -$135.0 million, which was down 14293.12% from -$46.5 million recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' Cash from Financing Activities peaked at $133.0 million during Q1 2024, and registered a low of -$513.7 million during Q4 2021.
  • In the last 5 years, Select Medical Holdings' Cash from Financing Activities had a median value of -$55.6 million in 2024 and averaged -$76.5 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 40050.33% in 2023, then surged by 378885.64% in 2024.
  • Quarter analysis of 5 years shows Select Medical Holdings' Cash from Financing Activities stood at -$513.7 million in 2021, then skyrocketed by 106.69% to $34.4 million in 2022, then crashed by 400.5% to -$103.3 million in 2023, then crashed by 77.18% to -$183.0 million in 2024, then rose by 26.24% to -$135.0 million in 2025.
  • Its Cash from Financing Activities was -$135.0 million in Q3 2025, compared to -$46.5 million in Q2 2025 and $49.3 million in Q1 2025.